B0405: R&D Portfolio Balancing Framework
A decision-ready template derived from the framework.
Name variants
- English
- B0405: R&D Portfolio Balancing Framework
- Katakana
- ポートフォリオ / フレームワーク
- Kanji
- 調整
Quality / Updated / Source / COI
- Quality
- Reviewed
- Updated
- Source
- Citations & Trust
- COI
- none
Context
Context: when teams interpret innovation yield, time-to-market, strategic fit and tech readiness, talent availability, budget envelope differently, decisions about r&d portfolio balancing framework become slow and inconsistent. Without a shared frame, the breakthrough bets versus incremental wins tradeoff stays implicit and accountability erodes. A concise decision record is required so future reviews can challenge assumptions without restarting the debate.
Options
- Option A: Maintain the current approach to minimize disruption while accepting limited improvement in innovation yield and time-to-market.
- Option B: Pilot changes in phases, validate against tech readiness, talent availability, budget envelope, and scale once the breakthrough bets versus incremental wins criteria hold.
- Option C: Redesign the approach end to end to pursue larger gains with higher execution risk and change cost.
Decision
Decision: Choose Option B. Validate assumptions for tech readiness, talent availability, budget envelope, confirm innovation yield, time-to-market, strategic fit baselines, and proceed only if the breakthrough bets versus incremental wins balance remains acceptable. Document thresholds, owners, constraints, and review dates so accountability stays clear.
Rationale
Rationale: Option B balances the breakthrough bets versus incremental wins tradeoff while preserving flexibility. It tests whether innovation yield, time-to-market, strategic fit respond as expected to tech readiness, talent availability, budget envelope before committing to a full rollout, reducing the risk of locking in a costly path based on weak evidence. The phased approach also strengthens governance by keeping decision criteria explicit and reviewable.
Risks
- Delayed data refresh can mask shifts in innovation yield, time-to-market, strategic fit and cause late responses to emerging risks.
- Execution slippage can erode confidence and widen breakthrough bets versus incremental wins costs before corrective action is taken.
Next
Next: Assign owners for innovation yield, time-to-market, strategic fit and tech readiness, talent availability, budget envelope, finalize baseline values, and publish trigger thresholds. Schedule the first review checkpoint, define escalation paths, and document stop conditions so the decision can be revisited quickly.